Radical Cystectomy in the Treatment of Invasive Bladder Cancer: Long-Term Results in 1,054 Patients

医学 膀胱切除术 膀胱癌 淋巴结 淋巴结切除术 解剖(医学) 外科 阶段(地层学) 泌尿科 癌症 内科学 生物 古生物学
作者
John P. Stein,Gary Lieskovsky,Rick Cote,Susan Groshen,An‐Chen Feng,Stuart D. Boyd,Eila C. Skinner,Bernard H. Bochner,Duriayai Thangathurai,Maged Mikhail,Derek Raghavan,Donald G. Skinner
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:19 (3): 666-675 被引量:3526
标识
DOI:10.1200/jco.2001.19.3.666
摘要

PURPOSE: To evaluate our long-term experience with patients treated uniformly with radical cystectomy and pelvic lymph node dissection for invasive bladder cancer and to describe the association of the primary bladder tumor stage and regional lymph node status with clinical outcomes. PATIENTS AND METHODS: All patients undergoing radical cystectomy with bilateral pelvic iliac lymphadenectomy, with the intent to cure, for transitional-cell carcinoma of the bladder between July 1971 and December 1997, with or without adjuvant radiation or chemotherapy, were evaluated. The clinical course, pathologic characteristics, and long-term clinical outcomes were evaluated in this group of patients. RESULTS: A total of 1,054 patients (843 men [80%] and 211 women) with a median age of 66 years (range, 22 to 93 years) were uniformly treated. Median follow-up was 10.2 years (range, 0 to 28 years). There were 27 (2.5%) perioperative deaths, with a total of 292 (28%) early complications. Overall recurrence-free survival at 5 and 10 years for the entire cohort was 68% and 66%, respectively. The 5- and 10-year recurrence-free survival for patients with organ-confined, lymph node-negative tumors was 92% and 86% for P0 disease, 91% and 89% for Pis, 79% and 74% for Pa, and 83% and 78% for P1 tumors, respectively. Patients with muscle invasive (P2 and P3a), lymph node-negative tumors had 89% and 87% and 78% and 76% 5- and 10-year recurrence-free survival, respectively. Patients with nonorgan-confined (P3b, P4), lymph node-negative tumors demonstrated a significantly higher probability of recurrence compared with those with organ-confined bladder cancers (P <.001). The 5- and 10-year recurrence-free survival for P3b tumors was 62% and 61%, and for P4 tumors was 50% and 45%, respectively. A total of 246 patients (24%) had lymph node tumor involvement. The 5- and 10-year recurrence-free survival for these patients was 35%, and 34%, respectively, which was significantly lower than for patients without lymph node involvement (P <.001). Patients could also be stratified by the number of lymph nodes involved and by the extent of the primary bladder tumor (p stage). Patients with fewer than five positive lymph nodes, and whose p stage was organ-confined had significantly improved survival rates. Bladder cancer recurred in 311 patients (30%). The median time to recurrence among those patients in whom the cancer recurred was 12 months (range, 0.04 to 11.1 years). In 234 patients (22%) there was a distant recurrence, and in 77 patients (7%) there was a local (pelvic) recurrence. CONCLUSION: These data from a large group of patients support the aggressive surgical management of invasive bladder cancer. Excellent long-term survival can be achieved with a low incidence of pelvic recurrence.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
刚刚
刚刚
刚刚
Akim的应助被Jam采纳,获得10
1秒前
远了个方发布了新的文献求助10
1秒前
1秒前
MARS完成签到,获得积分10
1秒前
科研通AI6.4的应助被七月流火采纳,获得30
1秒前
1秒前
dou完成签到 ,获得积分10
2秒前
2秒前
周小福完成签到,获得积分10
2秒前
2秒前
2秒前
科研通AI65的应助被云隐采纳,获得10
2秒前
2秒前
luna发布了新的文献求助30
3秒前
3秒前
巴拉巴拉发布了新的文献求助10
3秒前
3秒前
高静完成签到,获得积分10
3秒前
李健的小迷弟的应助被什么瑄采纳,获得10
3秒前
咿呀完成签到,获得积分10
3秒前
科研通AI2S的应助被天蓬猪大帅采纳,获得10
3秒前
嘤嘤嘤发布了新的文献求助10
4秒前
FAN发布了新的文献求助50
4秒前
4秒前
4秒前
远了个方发布了新的文献求助10
4秒前
4秒前
5秒前
yciDo完成签到,获得积分10
5秒前
5秒前
卿筱枫完成签到,获得积分10
6秒前
Stream完成签到,获得积分10
7秒前
7秒前
7秒前
远了个方发布了新的文献求助10
7秒前
远了个方发布了新的文献求助10
7秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193684
求助须知:如何正确求助?哪些是违规求助? 9579855
关于积分的说明 21867890
捐赠科研通 7793357
什么是DOI,文献DOI怎么找? 3437385
关于科研通互助平台的介绍 2560783
邀请新用户注册赠送积分活动 2484193